Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00374582 · ClinicalTrials.gov registry record · NA

End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

A NA study of End Stage Liver DIsease, sponsored by University of Cincinnati.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00374582 is a NA study of End Stage Liver DIsease that has completed, run by University of Cincinnati. The registered enrollment target is 30 participants, below the 489-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00374582, a NA study of End Stage Liver DIsease, has completed, sponsored by University of Cincinnati.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)

Conditions Studied

End Stage Liver DIsease

Interventions

  • DEVICE Bodystat Quadscan 4000
  • DEVICE bodystat quadscan 400

Study Locations (1)

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-09
Est. Completion 2008-05
Phase NA

Sponsor

University of Cincinnati

245 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00374582

The ClinicalTrials.gov registry entry for NCT00374582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 489-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (94% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Liver DIsease appearing as the primary indexed condition, and to 2 interventions - of which Bodystat Quadscan 4000 is the first listed.

NCT00374582 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00374582 about?

NCT00374582 is a clinical study titled "End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)". The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)

What is the current status of trial NCT00374582?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-09. Estimated completion is 2008-05.

What conditions does trial NCT00374582 study?

This clinical trial studies the following conditions: End Stage Liver DIsease.

What interventions are being tested in trial NCT00374582?

The interventions under investigation include: Bodystat Quadscan 4000 (DEVICE), bodystat quadscan 400 (DEVICE).

Who is sponsoring clinical trial NCT00374582?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00374582 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Liver DIsease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Liver DIsease

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.